Company intelligence / Profile preview
Myralis
Valinhos, São Paulo, Brazilmyralis.com.br ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Myralis specializes in the development and distribution of pharmaceutical products with a focus on innovation to improve health and wellbeing. The company has experienced rapid growth, reporting a 40% compound annual growth rate over five years. It has modernized its operations through cloud-based infrastructure to support business expansion
- Modalities
- small moleculesgenerics
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
SantoDigital (for cloud migration/IT infrastructure)
Beyond the preview
Go deeper on Myralis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myralis.